Clinical trial
Prospective Observational Study Investigating Genomic Determinants of Outcome From Cardiogenic Shock (GOlDilOCS)
NCT05728359 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study Investigating Genomic Determinants of Outcome From Cardiogenic Shock (GOlDilOCS)
- Lead sponsor
- Barts & The London NHS Trust
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 8, 2022
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiogenic shock